Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK
Apply
Mirdametinib & Vinblastine
Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step